Citius Oncology (CTOR) Times Interest Earned (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Times Interest Earned of -$4.16 for Q1 2026, up 98.31% year-over-year from -$2.1 in Q1 2025, and down 2533.13% quarter-over-quarter from -$0.16 in Q4 2025.
Citius Oncology (CTOR) Times Interest Earned (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Times Interest Earned for 4 consecutive years, with -$4.16 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 98.31% year-over-year to -$4.16; the TTM figure through Mar 2026 stood at -$6.32 (up 95.2% YoY), while the FY2025 annual figure was -$4.37, down 149.14% from the prior year.
- Times Interest Earned retreated to -$4.16 in Q1 2026 per CTOR's latest filing, from -$0.16 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.11 in Q2 2025 and bottomed at -$246.03 in Q1 2025.
- Historically, Times Interest Earned has averaged -$60.7 across 4 years, with a median of -$9.01 in 2024.
- On a YoY basis, Times Interest Earned climbed as much as 99.93% in 2025 and fell as far as 5466.6% in 2025.
- Citius Oncology's Times Interest Earned stood at -$149.93 in 2023, then soared by 90.92% to -$13.61 in 2024, then surged by 98.84% to -$0.16 in 2025, then sank by 2533.13% to -$4.16 in 2026.
- Business Quant data shows CTOR's Times Interest Earned at -$4.16 in Q1 2026, -$0.16 in Q4 2025, and -$35.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -3.15 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 114.07 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.05 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 52.24 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 4.20 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Citius Oncology | 76.60 Mn | 76.60 Mn | 1.00 Mn | -37.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.16 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -35.75 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -246.03 |
| Dec 31, 2024 | -13.61 |
| Jun 30, 2024 | -152.62 |
| Mar 31, 2024 | -4.42 |
| Dec 31, 2023 | -149.93 |
| Sep 30, 2023 | -0.19 |